Skip to main content
. 2016 Feb 1;18(4):375–383. doi: 10.1111/dom.12619

Figure 1.

DOM-12619-FIG-0001-b

Flow of participants through the main 6‐month period of the EDITION JP 1 study [modified intention‐to‐treat (mITT) and safety populations]. Gla‐100, insulin glargine 100 U/ml; Gla‐300, insulin glargine 300 U/ml.